Lori Leslie

4PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 26, 2025
Updates on the Biological Heterogeneity of Mantle Cell Lymphoma.

Andrew Ip, Maciej Kabat, Lindsay Fogel

|Mar 31, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.

Jason R Westin, Frederick L Locke, Michael Dickinson

|Oct 07, 2022
Clinical and economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia.

Lori A Leslie, Nilesh Gangan, Hiangkiat Tan

|Mar 08, 2021
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma.

Nathan H Fowler, Felipe Samaniego, Wojciech Jurczak

Pageof 1

Frequent Collaborators

2 joint publications

John M Pagel

1 joint publications

Enrico Derenzini

1 joint publications

Chan Y Cheah

1 joint publications

Tycel Phillips